HSD42 Modelling Time and Costs Associated With Daratumumab Treatment Delivery in the Home Care Setting Versus the Hospital in Spain to Understand Potential Benefits to Patients and Hospitals
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1385
https://www.valueinhealthjournal.com/article/S1098-3015(22)03590-2/fulltext
Title :
HSD42 Modelling Time and Costs Associated With Daratumumab Treatment Delivery in the Home Care Setting Versus the Hospital in Spain to Understand Potential Benefits to Patients and Hospitals
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03590-2&doi=10.1016/j.jval.2022.09.1385
First page :
Section Title :
Open access? :
No
Section Order :
10937